Does DURVALUMAB Cause Hepatitis c? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatitis c have been filed in association with DURVALUMAB (IMFINZI). This represents 0.0% of all adverse event reports for DURVALUMAB.
5
Reports of Hepatitis c with DURVALUMAB
0.0%
of all DURVALUMAB reports
1
Deaths
2
Hospitalizations
How Dangerous Is Hepatitis c From DURVALUMAB?
Of the 5 reports, 1 (20.0%) resulted in death, 2 (40.0%) required hospitalization.
Is Hepatitis c Listed in the Official Label?
Yes, Hepatitis c is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Hepatitis c?
RIBAVIRIN (2,130)
SOFOSBUVIR (1,662)
LEDIPASVIR\SOFOSBUVIR (1,076)
OXYCODONE (713)
SIMEPREVIR (537)
SOFOSBUVIR\VELPATASVIR (510)
ACETAMINOPHEN\OXYCODONE (499)
ACETAMINOPHEN\HYDROCODONE (497)
PEGINTERFERON ALFA-2A (482)
HYDROMORPHONE (430)
Which DURVALUMAB Alternatives Have Lower Hepatitis c Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE